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Abstract
Peripheral blood mononuclear cells (PBMCs) have been shown to produce and release a plethora of pro-angiogenetic
factors in response to γ-irradiation, partially accounting for their tissue-regenerative capacity. Here, we investigated
whether a certain cell subtype of PBMCs is responsible for this effect, and whether the type of cell death affects the
pro-angiogenic potential of bioactive molecules released by γ-irradiated PBMCs. PBMCs and PBMC subpopulations,
including CD4+ and CD8+ T cells, B cells, monocytes, and natural killer cells, were isolated and subjected to high-dose
γ-irradiation. Transcriptome analysis revealed subpopulation-speciﬁc responses to γ-irradiation with distinct activation
of pro-angiogenic pathways, cytokine production, and death receptor signalling. Analysis of the proteins released
showed that interactions of the subsets are important for the generation of a pro-angiogenic secretome. This result
was conﬁrmed at the functional level by the ﬁnding that the secretome of γ-irradiated PBMCs displayed higher pro-
angiogenic activity in an aortic ring assay. Scanning electron microscopy and image stream analysis of γ-irradiated
PBMCs revealed distinct morphological changes, indicative for apoptotic and necroptotic cell death. While inhibition
of apoptosis had no effect on the pro-angiogenic activity of the secretome, inhibiting necroptosis in stressed PBMCs
abolished blood vessel sprouting. Mechanistically, we identiﬁed tumor necrosis factor (TNF) receptor superfamily
member 1B as the main driver of necroptosis in response to γ-irradiation in PBMCs, which was most likely mediated via
membrane-bound TNF-α. In conclusion, our study demonstrates that the pro-angiogenic activity of the secretome of
γ-irradiated PBMCs requires interplay of different PBMC subpopulations. Furthermore, we show that TNF-dependent
necroptosis is an indispensable molecular process for conferring tissue-regenerative activity and for the pro-
angiogenic potential of the PBMC secretome. These ﬁndings contribute to a better understanding of secretome-based
therapies in regenerative medicine.
Introduction
Regenerative medicine, aiming at restoring damaged
tissues and organs, has become an emerging branch of
translational research in the last century worldwide1.
However, despite major advances in drug therapies, sur-
gical interventions, and organ transplantation, regenera-
tion of injured organs still remains a major obstacle2. A
promising new therapeutic avenue may be offered by stem
cell-based therapies, on which numerous pre-clinical
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studies, investigating their efﬁcacy and mechanisms have
been conducted3–6. Unfortunately, translation of experi-
mental in vitro studies or animal models to the patient has
been shown to be extremely difﬁcult if not impossible7. In
addition, an increasing number of studies suggests that
not stem cells themselves, but rather the factors released
from stem cells are important and sufﬁcient to promote
tissue regeneration8,9.
In 2005, Thum et al.10 speculated that stem cells
undergo apoptosis while being processed for clinical
applications and thus induce immunomodulatory and
tissue-regenerative effects. In addition, the authors
doubted the uniqueness of stem cells and suggested that
any other nucleated apoptotic cell type would exhibit
tissue-regenerative features10. The ﬁrst study providing
evidence for tissue repair by stressed peripheral blood
mononuclear cells (PBMCs) was performed by
Ankersmit et al.11. Enhanced regeneration was observed
in acute myocardial infarction (AMI) by applying γ-
irradiated PBMC suspensions intravenously. In sub-
sequent years, we were able to show that the application
of the PBMC secretome alone causes tissue repair in
AMI12–14, stroke15, spinal cord16, and skin wounds17–19,
in small and clinically relevant large animals. Although a
previous study from our group suggested that γ-irra-
diation is able to induce apoptosis and necroptosis20, a
contribution of necroptosis to tissue regeneration by the
release of paracrine factors has not been investigated
so far.
In contrast to necrosis, an uncontrolled form of cell
death, apoptosis had already been described as a well-
controlled form of programmed cell death decades ago21.
Later, also a programmed form of necrosis, termed
necroptosis22,23. The two forms of programmed cell death
differ morphologically as well as mechanistically from one
another. Morphologically, apoptosis is characterized by
karyorrhexis, pyknosis, and blebbing of the plasma
membrane22. By contrast, necroptotic cells exhibit trans-
lucent cytoplasms, oncosis, and permeabilization of the
lysosomal and plasma membranes, while nuclei remain
intact22,23. Instead of caspase activation, necroptosis
involves receptor-interacting protein kinase‐1 (RIPK1),
RIPK3, and mixed lineage kinase domain‐like (MLKL)
activation24. Tumor necrosis factor-α (TNF-α) is one of
the best characterized inducers of apoptosis, activating the
caspase-8 signalling cascade. However, due to partially
overlapping upstream signalling elements, TNF can also
activate the necroptotic pathway, which is favored by
impaired caspase activity23. Whereas the role of necrop-
tosis in several pathological conditions, including ather-
osclerosis25, myocardial infarction26, traumatic brain
injury27, and infections28 have been investigated so far, the
effects of the necroptotic cells on surrounding tissues
remains poorly understood.
Although several biological effects of paracrine factors
released from stressed PBMCs have already been inves-
tigated, the mechanisms by which these factors exert their
pro-angiogenic and tissue-regenerative activities have not
been fully elucidated so far17. In the current study, we
therefore addressed two major questions: (1) is the pro-
angiogenic potential of the secretome of γ-irradiated
PBMC cell type-dependent and (2) does the type of pro-
grammed cell death contribute to the pro-angiogenic
property of γ-irradiated PBMC secretome (Fig. 1).
Materials and methods
Ethics vote
Heparinized blood samples for PBMC isolation were
obtained from healthy volunteers at the Department for
Blood Transfusion Medicine of the Medical University of
Vienna (ethics committee vote: EK-Nr 1539/2017). All
donors provided informed written consent. For ex vivo
angiogenesis experiments, mouse experiments were per-
formed according to recent Austrian guidelines for the
use and care of laboratory animals and approved by the
Animal Research Committee of the Medical University of
Vienna (Protocol No. 190097/2015/9).
Isolation of PBMCs and PBMC subsets and production of
the secretomes
Cell secretomes were produced as described pre-
viously27. Brieﬂy, PBMCs were isolated using density
gradient centrifugation via Ficoll-Paque PLUS (GE
Healthcare Bio-Sciences AB, Sweden). Heparinized blood
was diluted with phosphate-buffered saline (PBS, Gibco
by Life Technologies, Carlsbad, CA, USA) and layered
carefully over Ficoll-Paque PLUS. After centrifugation
(800 × g, 15 min, room temperature, with slow accelera-
tion and deceleration), buffy coat containing PBMCs was
enriched at the interface between Ficoll-Paque PLUS and
plasma. For puriﬁcation of monocytes (CD14), natural
killer cells (CD56), CD4+ T cells (CD4), CD8+ T cells
(CD8), and B cells (CD19), magnetic microbeads (Milte-
nyi, Bergisch Gladbach, Germany) against the respective
cell surface epitope were used to enrich cells by Auto-
Macs Pro technology (Miltenyi) according to the manu-
facturer’s protocol. Purity of isolated cells was conﬁrmed
by ﬂow cytometry and ranged from 93 to 99% (Supple-
mentary Fig. 1). Whole PBMCs and puriﬁed cell subsets
were resuspended in CellGro serum-free medium (Cell-
Genix, Freiburg, Germany), irradiated, and cultivated for
24 h at a concentration of 25 × 106 cells/ml in the same
medium. γ-Irradiation of isolated PBMCs and puriﬁed
PBMC subsets with Cesium-137 (60 Gy) was conducted
as described previously29. To evaluate dose-dependent
effects of γ-irradiation, PBMCs were irradiated with 0.9,
1.9, 3.75, 7.5, 15, 30, and 60 Gy. For inhibition of apoptosis
and necroptosis, 20 µM zVAD and 100 μM necrostatin-1
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(both Sellekchem, Munich, Germany) were added
immediately after irradiation. After 24 h of incubation,
supernatants were collected by centrifugation (400 × g,
9 min) and stored at −20 °C. Cells were used for ﬂow
cytometric analysis and lysed for protein and messenger
RNA (mRNA) analyses as described below.
Imaging ﬂow cytometry analysis
Imaging ﬂow cytometry analysis (Amnis ImageStreamX
Mk II, Luminex Corp., Seattle, WA) was performed
according to a published protocol using Annexin-V-
FLUOS Staining Kit (Roche, Basel, Switzerland) according
to the manufacturer’s instruction30.
Scanning electron microscopy
For scanning electron microscopy (SEM), PBMCs were
either irradiated with 60Gy or left untreated, washed twice
with PBS, ﬁxed in Karnovsky’s ﬁxative (2% paraformalde-
hyde, 2.5% glutaraldehyde in 0.1M phosphate buffer (pH
7.4); Morphisto, Frankfurt am Main, Germany), dehydrated,
and dried with hexamethyldisilazane (HMDS, Sigma-Aldrich,
Taufkirchen, Germany). Samples were ﬁxed to specimen
mounts with double-faced adhesive carbon tape, gold sput-
tered (Sputter Coater, ACE200, Leica Microsystems, Wetzlar,
Germany), and examined by a SEM (JSM 6310, Jeol Ltd®,
Japan) with an acceleration voltage set to 15 kV.
Western blot analysis
Cells for Western blot analysis were lysed in Lämmli
Buffer (Bio-Rad, Hercules, CA, USA) with protease inhi-
bitors (Thermo Fisher, Waltham, MA, USA) and sodium
orthovanadate (Sigma Aldrich, St. Louis, MO, USA)
according to the manufacturer’s protocol. Thirty micro-
grams of total protein were separated on ExcelGels (GE
Healthcare) and transferred onto nitrocellulose mem-
branes (Bio-Rad). After blocking, membranes were incu-
bated with primary antibodies [cleaved caspase-3 antibody
(0.5 µg/ml, #MAB835; R&D Systems, Minneapolis, MN,
USA), phospho-RIPKs 1 (1:100, #65746; Cell Signalling
Technology, Cambridge, UK), phospho-RIPK3 (1:200,
#ab209384; Abcam, Cambridge, UK), phospho-MLKL
(1:500, #91689; Cell Signalling Technology, Cambridge,
UK), or glyceraldehyde 3-phosphate dehydrogenase
(1:2000, #2118; Cell Signalling Technology, TNF (1 µg/ml,
R&D Systems)] overnight at 4 °C. After further incubation
with horseradish-conjugated goat-anti-rabbit antibody
(1:10,000, #170-6515; Bio-Rad, Hercules, CA, USA), sec-
ondary antibodies were visualized with Supersignal West
Dura (Thermo Fisher, Waltham, MA, USA) and signals
were detected using ChemiDoc System (Bio-Rad). For
blocking of the TNF antibody, 1 µg TNF antibody was
pre-incubated with 10 µg recombinant TNF (R&D Sys-
tems) for 4 h at 4 °C:
Fig. 1 Schematic illustration of experimental approach. a To determine respective contributions of PBMC subsets to tissue-regenerative
properties of secreted factors, secretomes obtained from PBMCs, and subpopulations were compared by gene expression analysis and proteome
proﬁler. Biological activities were analyzed by functional assays using reporter gene constructs, protein phosphorylation, and aortic ring-assisted
endothelial cell sprouting. b To assess whether the type of programmed cell death affects pro-angiogenic potency of PBMC secretome, dying cells
were categorized by image stream and activated intracellular signalling cascades were investigated by Western blotting. Eventually, pro-angiogenic
property of apoptotic and necroptotic PBMC secretomes was compared by aortic ring sprouting assay
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TNF receptor blockade
PBMCs were treated with zVAD and neutralizing anti-
bodies against TNF receptor superfamily member 1A
(TNFRSF1A), TNFRSF1B (both 1 µg/ml, R&D Systems),
or both were added. Cell lysates were obtained 24 h after
irradiation.
Total RNA isolation
Total RNA was isolated from PBMCs and PBMC sub-
sets immediately after cell puriﬁcation as well as 24 h after
irradiation with 60 Gy using Trizol® Reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instruc-
tions. Total RNA was quantiﬁed using NanoDrop-1000
spectrophotometer (Peglab, Erlangen, Germany) and
RNA quality was assessed by Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). All RNA
samples used in further procedures displayed an RNA
integrity score between 6.2 and 10.
Microarray analysis
Microarray analysis was carried out at the Genomics
Core Facility at the Medical University of Vienna (Vienna,
Austria) using Affymetrix Human Transcriptome Array
2.0 (Affymetrix part of Thermo Fisher Scientiﬁc Inc.)
according to MIAME guidelines31. Data were analyzed
using GeneSpring Version 15.0 software (Agilent). First,
raw data were log 2 transformed, normalized by quintile
normalization, and baseline transformed. Thereafter, a
ﬁltering step was performed in order to reduce the
number of multiple hypotheses and to obtain only genes
for which at least 75% of the values in one sample (0 h vs.
irradiated) were above the 60th percentile of the average
expression value32. Moderated paired t test was used to
identify differentially expressed mRNA with a fold change
(FC) ≤−2 and ≥2, respectively. P values were corrected
for multiplicity by applying Benjamini–Hochberg adjust-
ment with a false discovery rate (FDR) <5%. mRNA
clustering was performed with GeneSpring software using
Euclidean distance metric and complete average-linkage
clustering. Microarray data were published on NCBI Gene
expression omnibus at https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE127982 (GEO Accession number
GSE127982). Full access is granted using the password:
qnuxcigibxmdfcf.
Gene ontology and pathway analysis
In order to evaluate biological functions of differentially
expressed genes in response to irradiation, we categorized
them using the WEB-based Gene Stet Analysis Toolkit
(WebGestalt)33. Gene ontology (GO)-term enrichment
analysis was performed to identify biological processes
that were enriched (geneontology.org). In addition,
pathway analysis was performed using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) annotation
list33. Benjamini–Hochberg method for multiple testing
with a signiﬁcance level of p ≤ 0.05 and FDR < 5% was
applied for both analyses. Activated canonical pathways
were identiﬁed using Ingenuity Pathway Analysis (Qiagen,
Hilden, Germany) with mRNAs displaying an average FC
>3 between 60-Gy-irradiated and freshly isolated
samples34,35.
Proteome proﬁler
Secretomes obtained from PBMCs and PBMC subsets
were analyzed using the commercially available Proteome
Proﬁler XL Cytokine Array and Human Apoptosis Array
(R&D Systems) according to the manufacturer’s instruc-
tions. Arrays were analyzed with the ChemiDoc system as
described above.
Aortic ring assays
Male C57BL/6 mice were purchased from The Jackson
Laboratory (Distributor Charles River, Sulzfeld, Germany)
and housed at the Center for Biomedical Research of the
Medical University of Vienna (Vienna, Austria). Mice
were sacriﬁced via cervical dislocation and aortas were
excised and sliced in 1-mm-thick rings (Supplementary
Fig. 2). The aortic ring assay was performed according to a
published protocol with minor alterations16. Aortic rings
were sandwiched in a ﬁbrin matrix composed of ﬁbrino-
gen (2 mg/ml, Merck Millipore, Burlington, MA, USA),
aprotinin (43.3 µg/ml, Sigma-Aldrich, St. Louis, MO,
USA), and thrombin (0.6 U/ml, Sigma-Aldrich) as
described previousy29. Sandwiched aortas were equili-
brated with M199 medium, supplemented with 100 μg/ml
streptomycin, 4 mM L-glutamine, 100 U penicillin (all
from Gibco), 250 ng/ml amphotericin B (Fisher Bior-
eagents, Fisher Scientiﬁc, Waltham, MA, USA), and 10%
fetal bovine serum (PAA Laboratories, Pasching, Austria),
for 45 min. After equilibration, the medium was removed
and supernatants of PBMCs and PBMC subfractions were
diluted in M199 medium corresponding to a ﬁnal con-
centration of 4 × 106 cells/ml. Aortas were cultured for
3 days. For some sprouting assays, PBMC-derived secre-
tomes generated with the addition of 20 µM zVAD and
100 μM necrostatin-1 directly after irradiation were
investigated. Secretomes of PBMCs with zVAD and
necrostatin-1 added immediately before starting the
sprouting assay were included as controls. Ultimately,
calcein dye (Thermo Fisher, Waltham, MA, USA) was
added to label viable cells. Sprouts were photographed by
Olympus IX83 scanning microscope (Olympus, Tokyo,
Japan) and visualized with cellSens Imaging Software
(Olympus, Tokyo, Japan). Sprouting areas were calculated
using the ImageJ software version 1.48v (Wayne Rasband,
National Institutes of Health, Bethesda, MD, USA).
Simader et al. Cell Death and Disease          (2019) 10:729 Page 4 of 15
Ofﬁcial journal of the Cell Death Differentiation Association
Tube formation assays
Primary human umbilical vein endothelial cells
(HUVECs) were cultivated in endothelial cell growth
medium (EGM-2, Lonza, Basel, Switzerland). Before
starting the tube formation experiment, cells were sub-
sequently starved with basal medium (EBM-2, Lonza,
without growth factors) supplemented with 2% FBS
(Gibco) for 12 h and without serum for 3 h. µ-Slide
angiogenesis tissue culture slides (Ibidi USA Inc., Fitch-
burg, WI, USA) were ﬁlled with growth factor reduced
Matrigel matrix (Corning, Corning, NY, USA), according
to manufacturer’s protocol. A total of 1 × 104 cells/well
were seeded and treated with PBMC-derived secretome
corresponding to a ﬁnal concentration of 4 × 106 cells/ml
or medium alone. PBMC secretomes generated with the
addition of 20 µM zVAD and 100mM necrostatin-1
directly after irradiation were also investigated. Secre-
tomes of PBMCs with zVAD and necrostatin-1 added
immediately before starting the tube formation assay were
included as controls. After 3 h of stimulation, micro-
photographs were taken and the number of nodes, junc-
tions, and branches were analyzed via Angiogenesis
Analyzer ImageJ plugin using default settings (Wayne
Rasband, National Institutes of Health, USA).
Reporter gene assays and potency assays
Reporter gene assays for activator protein-1 (AP-1),
nuclear factor ‘kappa-light-chain-enhancer’ of activated B
cells (NF-κB), and heat-shock protein 27 (HSP-27)
developed at Synlab Pharma Institute AG (Bern, Swit-
zerland) were used to compare the potential of the dif-
ferent secretomes to activate these pathways. Human
neuroblastoma SH-SY5Y cells were cultured in Ham’s
F12/MEM (50:50) Glutamax (Gibco) supplemented with
1 µg/ml puromycin, 2 mM L-glutamine, and non-essential
amino acid solution (all from Sigma-Aldrich, St. Louis,
MO, USA), 15% fetal bovine serum and SH-SY5Y cells
were stably transfected with a ﬁreﬂy luciferase tran-
scriptionally regulated by AP-1 promoter. Cells were
seeded in 96-well plates at a concentration of 20,000 cells
per well and stimulated with secretomes of γ-irradiated
monocyte supernatant and PBMCs, both pooled from
four donors. To evaluate reporter activity, SteadyGlo
(Promega, Fitchburg, WI, USA) was added and lumines-
cence was measured via luminescence reader (EnVision,
Perkin-Elmer or Centro LB960, Berthold). To quantify
phosphorylation of HSP-27 at Ser82, adenocarcinomic
human alveolar basal epithelial cells (A549) were treated
with supernatants for 30 min, ﬁxed, and permeabilized.
After sequential addition of antibodies directed against
the phosphorylated form of HSP-27 and peroxidase-
conjugated antibody, chemiluminescent signals were
measured with the luminescence reader (EnVision,
Perkin-Elmer or Centro LB960, Berthold) and relative
potency was calculated with the PLA software (Stegmann
Systems GmbH, Rodgau, Germany).
Enzyme-linked immunosorbent assay
TNF-α (R&D Systems) and lymphotoxin A (LTA; R&D
Systems) were quantiﬁed by enzyme-linked immunosor-
bent assay according to the manufacturer’s instructions.
Graphical overview
The methodological approach was designed using the
InDesign CS software (version 7.0, Adobe Systems Inc.,
San Jose, CA, USA) and is shown in Fig. 1.
Statistical analysis
Data were analyzed using GraphPad Prism 6 software
(GraphPad Software Inc., La Jolla, CA, USA) and IBM
SPSS Statistics version 23 (SPSS Inc., Chicago, IL, USA).
Two-tailed Student’s t test was used to compare para-
metric variables and stated as arithmetic mean ± standard
deviation (SD). One-way analysis of variance with Bon-
ferroni post hoc test or Kruskal–Wallis with Dunn’s post
hoc test was used according to data distribution. Aber-
rations were excluded according to the Gibbs outlier test.
P values below 0.05 were considered statistically sig-
niﬁcant and are marked with asterisks.
Results
γ-Irradiation differentially affects transcriptional proﬁles of
PBMCs and puriﬁed cell subsets
To assess the impact of γ-irradiation on transcriptional
networks of PBMCs and PBMC subsets, we conducted
mRNA microarray analysis four different healthy volun-
teers with and without γ-irradiation. In total, 756 anno-
tated genes were differentially expressed in PBMCs and
PBMC subsets (Supplementary Table 1). Global gene
expression analysis showed signiﬁcant differences
between stressed PBMCs and stressed puriﬁed cell types
(Fig. 2a, b). Principal component analysis of global gene
expression patterns showed a clear distinction between
the different cell types except for natural killer (NK) and
CD4+ T cells, which clustered together, suggesting high
transcriptional similarity (Fig. 2b). Monocytes, B cells, and
PBMCs displayed markedly distinct global gene expres-
sion patterns. Canonical pathway analysis of genes upre-
gulated by γ-irradiation in PBMCs suggested activation of
death receptors, upregulation of TNF receptor 2
(TNFRSF1B) signalling, and induction of apoptosis.
Moreover, we identiﬁed activation of cytokine and cell
signalling pathways, including NF-κB and the stress-
activated protein kinase c-Jun-N-terminal kinase, both of
which are linked to tissue-regenerative and angiogenic
processes (Fig. 2c)36–38.
To gain more detailed biological information on the
pathways identiﬁed, we investigated expression proﬁles of
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key signalling molecules of these pathways in the different
cell subsets. Selected genes involved in the processes of
cytokine production (Fig. 3a and Supplementary Table 2),
angiogenesis (Fig. 3b and Supplementary Table 3), and
wound healing (Fig. 3c and Supplementary Table 4) dis-
played notable differences in their expression pattern in
PBMCs compared to PBMC subsets. GO-term and
KEGG-pathway analyses of genes induced by γ-irradiation
(Fig. 3d–i) reﬂected the differences observed on tran-
scriptional level also in a functional context. All selected
biological functions, including cytokine production (Fig.
3d), response to hypoxia (Fig. 3e), and cell cycle (Fig. 3f),
as well as the tumor growth factor-β (TGF-β) pathway
(Fig. 3g), mitogen-activated protein kinase (MAPK)
pathway (Fig. 3h), and p53 pathway (Fig. 3i) varied sig-
niﬁcantly between the different cell groups. While genes
encoding cytokines were strongly enriched in PBMCs and
NK cells (Fig. 3d), genes constituting the TGF-β signalling
pathway were found mainly activated in PBMCs, CD14
monocytes, and CD8+ T cells (Fig. 3g). Genes associated
with stress response (response to hypoxia) were exclu-
sively enriched in irradiated PBMCs (Fig. 3e), while the
MAPK pathway was most upregulated in monocytes (Fig.
3h). Cell cycle genes were enriched after irradiation in
PBMCs as well as in B cells and CD8+ T cells (Fig. 3f),
whereas genes involved in the p53 signalling were sig-
niﬁcantly enriched in all samples evaluated, showing
strongest activation in PBMCs (Fig. 3i). In conclusion,
results presented here indicate that various signalling
pathways and biological processes are differentially regu-
lated after γ-irradiation in the respective cellular subsets
constituting PBMCs. Moreover, cell populations are in
reciprocal relationships which, although mutually, differ-
entially inﬂuence cellular signalling events in PBMCs.
Fig. 2 γ-Radiation differentially affects gene expression of PBMCs and puriﬁed cell subsets. a Heat map showing expression values of 910
transcripts differentially expressed between non-irradiated cells and cells 24 h after irradiation. Fold expression ranged from −2.7 (red,
downregulation) to 2.7 (blue, upregulation). Each cell subset exhibited a unique expression pattern. b Principal component analysis (PCA) of global
gene expression pattern clearly showed clustering of cell subsets, indicating a strong homogeneity within each cell fraction and different donors, but
heterogeneity between all cell fractions. c Visualization of overrepresented GO terms in irradiated PBMCs is shown. Each node represents a biological
process-speciﬁc term. Node size indicates p value, node color was selected to group terms according to their function (blue, apoptosis; green, pro-
inﬂammatory signalling; purple, cell cycle). Ratios indicate relative amounts of activated genes per pathway. Among the most enriched terms were
“TNFRSF1B signalling,” “apoptosis induction,” and “death receptor signalling.” n= 4 donors per group
Simader et al. Cell Death and Disease          (2019) 10:729 Page 6 of 15
Ofﬁcial journal of the Cell Death Differentiation Association
γ-Irradiated PBMC subpopulations synergistically induce
blood vessel sprouting
As we have previously described a strong tissue-
regenerative and pro-angiogenic activity of the secre-
tome derived from γ-irradiated PBMCs29,39, and since our
bioinformatics analysis revealed differential transcrip-
tional signatures, we now asked whether a speciﬁc cell
subtype of PBMCs would account for the observed effects.
We therefore performed aortic ring assays with super-
natants from γ-irradiated PBMCs, NK cells, monocytes,
CD4+ T cells, CD8+ T cells, and B cells. As shown in Fig.
4a, b, strongest pro-angiogenic activity was observed in
aortic rings cultured with the secretome of whole PBMCs.
Intriguingly, monocytes displayed vessel sprouting-
inducing capacity, which was higher compared to med-
ium, yet compromised compared to that of the PBMC-
derived secretome. Stimulation of aortic rings with
secretomes derived from NK cells, CD4+ and CD8+
T cells, and B cells showed no increased pro-angiogenic
effects compared to control medium (not shown) in our
assay system (Fig. 4a, b). We furthermore sought to proﬁle
the speciﬁc protein signatures obtained from PBMCs and
subsets. Analysis of cytokines revealed that certain cyto-
kines, including matrix metallopeptidase-9, interleukin-
18Bpa (IL-18Bpa), osteopontin, epithelial derived
neutrophil attractant-78, IL-8, RANTES (regulated on
activation, normal T cell expressed and secreted), angio-
genin, and IL-1ra were exclusively detected in the
Fig. 3 Tissue-regenerative potential varies between PBMCs and puriﬁed cell subsets. Genes associated with the biological process of a
cytokine production (742 genes), b angiogenesis (509 genes), and c wound healing (361 genes) (mean values of four samples) revealed
transcriptional heterogeneity between the different puriﬁed cells subsets and PBMCs. Expression values ranged from log(2)= 1 (red, low expression)
to log(2)= 9 (blue, strong expression). GO-term enrichment analysis for d “cytokine production,” e ”response to hypoxia,” and f “cell cycle” as well as
KEGG-pathway enrichment analysis for g “TGF-β”, h “MAPK”, and i “p53 pathway” are shown. Irradiated PBMCs (highlighted in red) uniformly enriched
genes associated with these biological processes and pathways, while individual cell subsets showed a more heterogeneous pattern. The analysis
was performed using Webgestalt platform. P values are represented as the minus base 10 log. n= 4 per group
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Fig. 4 (See legend on next page.)
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supernatant of γ-irradiated PBMC (Fig. 4c, Supplemen-
tary Fig. 4). Since pro-angiogenic activity was unique to
secretomes of PBMC and monocytes, we next compared
the capability of these secretomes to activate signalling
pathways known to be involved in tissue-regenerative and
pro-angiogenic processes. Interestingly, NF-κB promoter
activity (Fig. 4d) and HSP-27 phosphorylation (Fig. 4e)
were strongly induced by PBMC-derived secretome, while
being only moderately activated by the secretome
obtained from irradiated monocytes. In contrast, both
secretomes comparably activated the AP-1 promotor (Fig.
4f). Together, our data suggest that secretomes of PBMC
subsets exhibit differential pro-angiogenic capacities and
that a synergistic action of γ-irradiated PBMC sub-
populations is necessary for efﬁcient release of pro-
angiogenic mediators.
High-dose γ-irradiation induces apoptosis and necroptosis
in PBMCs
Since our bioinformatics analysis suggested an activa-
tion of death receptors and an involvement of TNF
receptor signalling, we were interested which type of cell
death is induced in PBMCs and PBMC subsets after γ-
irradiation. We therefore assessed cellular morphology,
indicative of the manner by which cells die, by SEM.
Intriguingly, we found comparable number of cells
showing morphological signs of either apoptosis or
necroptosis in irradiated PBMCs (Fig. 5a). Interestingly,
the levels of cells displaying either apoptotic or necrop-
totic features varied signiﬁcantly between different
populations (Fig. 5b). As already observed by electron
microscopy, quantiﬁcation of apoptotic and necroptotic
cells in γ-irradiated PBMCs conﬁrmed an almost equal
abundance (22% apoptotic vs. 28% necroptotic) of both
forms of controlled cell death. In contrast, most of NK
cells were necroptotic (3% apoptotic vs. 94% necroptotic).
Although around half of CD4+ and CD8+ T cells
underwent necroptosis, the highest number of apoptotic
cells were also detected in these populations (CD8+
T cells: 21% apoptotic vs. 54% necroptotic; CD4+ T cells:
37% apoptotic vs. 45% necroptotic). By contrast, B cells
and monocytes displayed low amounts of apoptotic cells
(B cells: 8% apoptotic vs. 68% necroptotic; monocytes: 5%
apoptotic vs. 59% necroptotic). These data were further
corroborated by an apoptosis protein array, showing that
the induction of proteins involved in the apoptotic pro-
cess was strongly induced in cell types that were mainly
driven into apoptotic cell death (Supplementary Fig. 5).
These results highlight the different susceptibilities of
PBMC subsets to preferentially undergo apoptosis or
necroptosis after high-dose γ-irradiation.
To assess kinetics and dose dependency of apoptosis
and necroptosis induction after γ-irradiation on the
molecular level, we evaluated cleavage of caspase-3 (c-cas
3) and phosphorylation of RIPK3 and MLKL, respectively
(Fig. 5c, d). MLKL phosphorylation, indicative of induc-
tion of necroptosis, occurred in a dose-dependent man-
ner, reaching its maximum at an irradiation dose of 15 Gy
(Fig. 5d). Comparably, caspase-3 cleavage was induced by
γ-irradiation starting from 30 Gy. For further character-
ization of the irradiation-induced programmed cell death,
phosphorylation of RIPK3, MLKL, and c-cas 3 was
assessed at different time points. While sustained phos-
phorylation of RIPK3 was detected starting from 2 h post
irradiation, phosphorylation of MLKL and caspase-3
cleavage displayed highest levels 24 h post irradiation
(Fig. 5c). Interestingly, we detected two smaller bands of
35 and 25 kDa in the phosphorylated (p)-RIPK3 Western
blot. In contrast to γ-irradiation, induction of RIPK3 and
MLKL phosphorylation by TNF-α and zVAD peaked as
soon as 2 h after stimulation (Supplementary Fig. 6) and
did not induce cleavage of p-RIPK3. Since MLKL phos-
phorylation occurs rapidly after induction of necroptosis,
our ﬁnding that MLKL phosphorylation peaked 24 h after
γ-irradiation suggests an indirect induction of necroptosis
in PBMCs after exposure to γ-radiation.
Pro-angiogenic capacity of PBMC secretome requires
irradiation-induced necroptosis
Next, we determined whether the type of cell death
affects the pro-angiogenic potential of PBMC secretome.
Therefore, irradiated PBMCs were cultivated in the pre-
sence of zVAD, a pan-caspase inhibitor, or necrostatin-1,
an inhibitor of necroptosis, and the angiogenic capacity of
the resulting secretome was assessed in murine aortic ring
sprouting assays (Fig. 6b, c) and tube formation assays
with HUVECs (Fig. 6d, e). Irradiation-induced c-cas 3 and
phosphorylation of MLKL were efﬁciently abrogated by
(see ﬁgure on previous page)
Fig. 4 Blood vessel sprouting is synergistically induced by γ-irradiated PBMC subpopulations. a Representative images of calcein-labelled
mouse aortic rings on day three of cultivation are shown. Scale bar, 250 µm. b Box plots of averaged outgrowth areas are shown. Whiskers indicate
minimal and maximal values. Quantitative analysis showed a signiﬁcant induction of sprouting blood vessels when adding the supernatant of PBMCs
as well as the supernatant of puriﬁed monocytes. *P values <0.05 compared to CellGro. c Analysis of cytokines present in the different secretomes
revealed that certain cytokines, including MMP-9, IL-18Bpa, osteopontin, ENA78, IL-8, RANTES, angiogenin, and IL-1ra, were exclusively detected in the
supernatant of γ-irradiated PBMC. d–f Tissue-regenerative capacity of secretomes of γ-irradiated PBMCs and monocytes was further assessed using
standardized reporter gene assays. NF-κB promoter activity and HSP-27 phosphorylation were strongly induced by PBMC supernatant, whereas AP-1
promotor was induced by PBMC and monocyte secretome. *P values <0.05 compared to CellGro. n= 4
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zVAD and necrostatin-1, respectively (Fig. 6a), indicating
that γ-irradiated PBMCs treated with zVAD and
necrostatin-1 preferentially undergo apoptosis or
necroptosis. In both assay systems, blood vessel sprouting
was strongly induced by the secretome of irradiated
PBMCs (Fig. 6b–e), as described above, and was com-
parably high with blocked caspase-dependent apoptosis
(zVAD, Fig. 6b–e). Intriguingly, the pro-angiogenic
capacity of the secretome was remarkably compromised
when necroptosis was inhibited by necrostatin-1 (Fig.
6b–e). Freshly added zVAD and necrostatin-1 to the
secretome of γ-irradiated PBMC during the assay had no
effect on vessel sprouting (Supplementary Fig. 7a). Our
data indicate that necroptosis represents an indispensable
prerequisite for the pro-angiogenic action of secretomes
derived from γ-irradiated PBMCs.
Necroptotic cell death in γ-irradiated PBMCs is induced via
paracrine activation of the TNFRSF1B
We next sought to elucidate the mechanism by which γ-
irradiation induces necroptosis in PBMCs. Since previous
studies identiﬁed the TNF-α pathway as one of the main
drivers of necroptosis, and our bioinformatics analysis
suggested an activation of the TNFRSF1B signalling
pathway in response to irradiation, we analyzed the
expression of TNF and its receptors (TNFRSF1A and
TNFRSF1B). Low TNF expression was detectable in
PBMCs and all subfractions, with highest mRNA levels in
Fig. 5 γ-irradiation differentially induces apoptosis and necroptosis in PBMC and puriﬁed cell subsets. a Representative scanning electron
microscopy images of viable, apoptotic, and necroptotic cells 24 h after irradiation. Scale bar, 10 μm. b Relative amounts of viable, apoptotic, and
necroptotic cells in PBMC and PBMC subpopulations. c Immunoblot analysis of receptor-interacting protein kinase-3 (p-RIPK3), pseudokinase mixed
lineage kinase domain-like phosphorylation (p-MLKL), and cleaved caspase (c-cas 3) in PBMC shows a time-dependent induction 24 h after γ-
irradiation. The position of an unidentiﬁed, most likely unspeciﬁc, band on the p-RIPK3 Western blot is indicated by an asterisk. d γ-Irradiation dose-
dependently induces phosphorylation of MLKL and caspase-3 cleavage. n= 3
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monocytes (Fig. 7a). Whereas TNFRSF1A showed little
expression values in PBMCs and PBMC subsets (Fig. 7b),
TNFRSF1B was strongly expressed in PBMCs and to a
minor degree in all subsets (Fig. 7c). Interestingly, we
neither detected soluble TNF-α nor LTA, a TNF homo-
logous ligand of TNFRSF1A and TNFRSF1B, in the
PBMC secretome (not shown). However, Western blot
analysis showed a signiﬁcant induction of membrane-
bound TNF (mTNF) in PBMC after γ-irradiation (Fig. 7d).
To further investigate the necroptosis signalling cascade,
we speciﬁcally blocked both TNF receptors of γ-irradiated
PBMCs with monoclonal blocking antibodies and asses-
sed MLKL phosphorylation. As shown in Fig. 7e, induc-
tion of necroptosis was only effectively abolished by
neutralizing antibody directed against TNFRSF1B, but not
by TNFRSF1A. Our data thus indicate that γ-irradiation-
induced necroptosis of PBMCs occurs via an mTNF-
TNFRSF1B signalling cascade.
Discussion
In the past, stem cell therapies had been praised as a
promising therapeutic option for tissue regeneration of a
variety of damaged organs40–43. Yet, most of the high
expectations from in vitro and animal experiments were
disappointed when stem cells employed in human clinical
trials showed only minor tissue-regenerative potential44.
We have reported previously that the release of regen-
erative factors is not an exclusive feature of stem cells,
Fig. 6 Induction of necroptosis is necessary for the pro-angiogenic capacity of the PBMC secretome. a Immunoblot analysis of
phosphorylated MLKL and cleaved caspase (c-cas) 3 in non-irradiated and γ-irradiated PBMCs is shown. Irradiated PBMCs were cultivated with either
zVAD, necrostatin-1, or both. b Representative images of murine aortic rings after 3 days of cultivation with conditioned medium from γ-irradiated
PBMC treated with zVAD, necrostatin-1, or both. Viable cells were visualized with calcein (green). Scale bar, 200 µm. c Box plot diagrams of vessel
areas are shown. Whiskers indicate minimal and maximal values. Necrostatin-1 added to irradiated PBMC signiﬁcantly reduced sprout-inducing ability
of the PBMC secretome, while addition of zVAD did not compromise pro-angiogenic potential. d Endothelial cells were incubated with the
secretome of γ-irradiated PBMCs alone or treated with zVAD or necrostatin for 3 h after overnight starvation. The PBMC secretome treated with
necrostatin-1 lead to signiﬁcantly reduced tube formation. e Bar graph depicting a signiﬁcant decrease in the number of nodes and junction after
treatment with necrostatin-1. Scale bar, 200 µm. *P values below 0.05 compared to PBMC. n= 3
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since secretomes derived from γ-irradiated PBMCs also
displayed high tissue-regenerative activity in various
experimental models. These regenerative effects were
mainly attributed to the secretomes’ pro-angiogenic and
cytoprotective properties12,13,16,18. These results raised the
question whether all cell types are potentially capable of
producing and releasing sufﬁcient factors with tissue-
regenerative properties after stress-induced cell death.
Our analyses revealed pronounced differences in gene
expression and released proteins between the respective
cell types and total PBMCs in response to γ-irradiation.
Importantly, certain cytokines were exclusively released
when irradiated PBMCs were cultured together, but were
not present in the secretomes derived from puriﬁed cell
populations. In addition, using murine aortic rings for
blood vessel sprouting assays, high pro-angiogenic activity
was only detected in secretomes from total PBMCs. Both
analyses suggest that a crosstalk of PBMC subpopulations
is required for the release of angiogenesis-promoting
factors. Therefore, our study argues against the initial
hypothesis that the secretome of any stressed cell type
exhibits tissue-regenerative characteristics and suggests
that paracrine communication between different cell
types is fundamental for the release of a unique compo-
sition of tissue-regenerating mediators. Thus, future
clinical studies on damaged tissue will elucidate the full
tissue-regenerative efﬁcacy of the PBMC-derived secre-
tome. Since toxicological studies and studies on the viral
safety of an allogeneic secretome from γ-irradiated PBMC
produced under Good Manufacturing Practice (GMP)
conditions have already been successfully conducted, our
study paves the way for a ﬁrst clinical trial in the indica-
tion of diabetic foot ulcer45,46.
Here, we also investigated the impact of the type of cell
death on the tissue-regenerative capacity of the secre-
tome. Although γ-radiation is a known inducer for both
apoptosis and necroptosis20,47–51, it is unknown whether
γ-radiation-induced necroptosis has tissue-regenerative
effects or further aggravates tissue damage. While Castle
et al.49 showed that mice lacking RIP3, a critical molecule
in the necroptosis pathway, were not rescued from acute
radiation syndrome, a protective activity of necrostatin-1
administration in mice after lethal full body irradiation
has been reported in several studies47,52. Although the
underlying mechanisms are still not known, the afore-
mentioned data by Huang et al.47 and Steinman et al.52
Fig. 7 TNFRSF1B mediates radiation-induced necroptosis via a paracrine mechanism. Expressions of TNF (a), TNFRSF1A (b), and TNFRSF1B (c)
assessed by microarray analysis are shown. TNF is expressed in PBMCs and in all subfractions. While expression of TNFRSF1A is low, TNFRSF1B is highly
expressed in PBMCs and cell subsets. d Western blot analysis shows induction of membrane-bound TNF (mTNF) in PBMCs after γ-irradiation (upper
panel). The speciﬁcity of the antibody was conﬁrmed by pre-absorption of the antibody with recombinant TNF (lower blot). e Immunoblot analysis of
phosphorylated MLKL in γ-irradiated PBMC treated with blocking antibodies against TNFRSF1A, TNFRSF1B, or a combination of both is shown.
Blocking TNFRSF1B, but not TNFRSF1A, reduced necroptosis induction as shown by reduced MLKL phosphorylation. Diagrams show means of four
independent experiments. Western blots show one representative experiment of 5
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suggest that inhibition of necroptosis by necrostatin-1 is
indeed favorable in a lethal setting, due to the prevention
of massive cell death and organ destruction. To the best of
our knowledge, our study is the ﬁrst to describe that
necroptosis of PBMCs exerts pro-angiogenetic effects,
thereby potentially contributing to tissue regeneration in
chronically damaged tissues. As shown by aortic ring
assays, addition of necrostatin-1 to PBMCs before irra-
diation abolishes its pro-angiogenic activity, indicating
that necroptosis is important for the release of factors
involved in blood vessel formation. However, since
PBMCs used in this study were ex vivo γ-irradiated and
then applied to the tissue, we do not currently know
whether similar processes are also present in stressed
tissue in vivo, or in tissues under physiological conditions.
Our study builds a basis for further studies, which would
address these questions in more sophisticated experi-
ments. Another interesting ﬁnding was the detection of
low molecular forms of phosphorylated RIPK3 after γ-
irradiation. Whether these forms are still active or only
non-functional degradation products occurring during
massive cell death after γ-irradiation remains to be
determined.
Here we identiﬁed the TNF/TNFRSF1B signalling
cascade as an inducer of necroptosis after γ-irradiation.
In line with our observations, recent guidelines of the
American College of Rheumatology instruct doctors to
stop medication with anti-TNF therapy before surgery
to avoid wound healing problems, highlighting the
importance of TNF for proper wound healing, pre-
sumably due to its necroptosis-inducing action53.
Interestingly, release of soluble TNF was not detectable
in our secretomes. However, Western blot analysis
revealed a signiﬁcant increase in membrane-bound
TNF. When analyzing TNF receptors, we found strong
expression of TNFRSF1B. This is in line with previous
studies, suggesting that mTNF preferentially signals
through TNFRSF1B54,55. Currently, the mechanism of
γ-radiation-induced necroptosis is still not fully under-
stood. While activation of necroptosis by TNF requires
additional inhibition of apoptosis (Supplementary Fig. 7b),
γ-irradiation simultaneously induced necroptosis and
apoptosis in PBMC22,56,57. Since high-dose ionizing
radiation leads to DNA damage, activation of cytosolic
DNA sensors could account for this phenomenon. Indeed,
the cytosolic DNA sensor DNA-dependent activator of
interferon regulatory factors has been shown to directly
induce necroptosis via RIPK3 after virus infection58.
Further studies are needed to investigate whether similar
mechanisms also account for the induction of necroptosis
in our experimental setting.
In conclusion, we could demonstrate that secretomes of
PBMCs and PBMC subsets show different tissue-
regenerative capacities, refuting the paradigm that any
cell type is able to release paracrine factors with regen-
erative potential. Furthermore, we identiﬁed the TNF/
TNFRSF1B signalling pathway as the mechanism under-
lying the γ-irradiation-induced release of pro-angiogenic
factors. Based on these ﬁndings we believe that necrop-
tosis, although seemingly paradox, is indeed an essential
prerequisite for tissue regeneration and that forced
induction of necroptosis might facilitate the development
of novel therapeutic approaches in the near future.
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